Skip to content

To study the efficacy of suparni varti anjan in pratham patalgat timir with special reference to simple myopia

A randomized controlled clinical trial to evaluate the efficacy of Suparni Varti Anjan in Pratham Patalgat Timir with special reference to simple myopia. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072916
Enrollment
80
Registered
2024-08-22
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H521- Myopia

Interventions

None listed

Sponsors

Dr Bhagyashri Vishnu Kumbhar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age Group: 10 to 21 years 2. A patient having classical symptoms of Timir will be selected. 3. Irrespective of sex, religion, education, and occupation, 4. The patient has a refractive error from -1.00 to -6.00 diopter.

Exclusion criteria

Exclusion criteria: 1. age group-below 10 years and above 21 years. Patients with pathological myopia and high myopia. 2. Patients with severe ocular conditions like retinoblastoma, leprosy, and malignant eye disease, corneal ulcers, ocular tumour, or retinoblastoma, as well as those with degenerative and retinal changes and Patients who are taking additional ocular medications 3. A recent eye operation was performed. 4. Patients with a refractive error below -1.00 and above -6.00 diopter.

Design outcomes

Primary

MeasureTime frame
Improvement in Visual AcuityTimepoint: 30 days study with Follow up on 0th 7th 15th 30th days

Secondary

MeasureTime frame
Improvement in Myopic RefractionTimepoint: 30 days study with Follow up on 0th 7th 15th 30th days

Countries

India

Contacts

Public ContactDr Bhagyashri Vishnu Kumbhar

LRP Ayurvedic Medical College and Hospital Islampur

drpravin222@gmail.com9623318318

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026